The value of interferon therapy for COVID-19 in children

The value of interferon therapy for COVID-19 in children

The article presents a literature review, which provides data on the role of interferons in the immunopathogenesis of COVID-19 and the clinical efficacy of drugs based on recombinant interferon-alpha 2b in the treatment of children with new coronavirus infection. Shown the leading role ofinterferons...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. N. Mazankova, S. G. Gorbunov, E. R. Samitova
Format:	Article
Language:	Russian
Published:	LLC "Diagnostics and Vaccines" 2021-04-01
Series:	Детские инфекции (Москва)
Subjects:	covid-19 sars-cov-2 interferon alpha 2b interferon therapy children
Online Access:	https://detinf.elpub.ru/jour/article/view/569
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of interferon types on COVID-19 prevention and treatment
by: S. S. Saidov, et al.
Published: (2021-10-01)

Evaluation of the effectiveness of antiviral therapy for coronavirus infection (COVID-19) with the inclusion of recombinant interferon alpha-2b
by: A. V. Mordyk, et al.
Published: (2022-10-01)

Evaluation of the effectiveness and safety of interferon alpha-2b ointment and gel for prevention of acute respiratory infections in organized groups
by: K. V. Kozlov, et al.
Published: (2024-04-01)

Cycloferon as a Means for Prevention, Treatment, and Control of COVID-19: Multidisciplinary and Comparative Historical Aspects
by: P. V. MAZIN, et al.
Published: (2022-09-01)

Рreventive efficacy of interferon -2b in the COVID-19 pandemic
by: Zh. B. Ponezheva, et al.
Published: (2021-06-01)

Clinical and Epidemiological Features of COVID-19 in Children in Moscow in 2020–2022
by: E. R. Samitova
Published: (2022-11-01)

Nonproductive exposure of PBMCs to SARS‐CoV‐2 induces cell‐intrinsic innate immune responses
by: Julia Kazmierski, et al.
Published: (2022-08-01)

The use of combined interferon alpha-2b-based medicine in the complex treatment of herpetic keratitis in patients after coronavirus infection
by: A. V. Surov, et al.
Published: (2023-07-01)

The common genetic variant rs1278960 determining expression of Interferon-lambda predicts inflammatory response in critically ill COVID-19 patients
by: Timo Mayerhöfer, et al.
Published: (2025-05-01)

Interferons alpha and gamma, pidotimod, and tilorone in the treatment of acute respiratory infections in patients with allergic rhinitis: a prospective, cohort clinical and immunological study
by: O. V. Kalyuzhin, et al.
Published: (2022-07-01)

Interferon alpha-2b addition to intravitreal bevacizumab for diabetic macular edema: a randomized controlled trial
by: Saeed Karimi, et al.
Published: (2025-04-01)

The efficiency of interferon therapy for acute respiratory viral infections in young children
by: T. K. Chudakova, et al.
Published: (2020-03-01)

Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids
by: Meaghan Flagg, et al.
Published: (2023-12-01)

IMMUNOPATHOGENESIS OF ACUTE RESPIRATORY INFECTIONS AND TACTICS OF RATIONAL CHOICE OF ETIOTROPIC IMMUNOMODULATORY THERAPIES IN CHILDREN
by: V. V. Malinovskaya, et al.
Published: (2015-08-01)

Cytokine status indicators in children with acute respiratory viral infections after treatment with intranasal interferon-based medicine
by: O. I. Afanasyeva, et al.
Published: (2021-12-01)

An Outbreak of a New Coronavirus Infection COVID-19 in an Educational Institution in Moscow
by: L N Mazankova, et al.
Published: (2022-03-01)

Results of using interferon α-2b in combination with vitamins E and C in the treatment of urogenital infections in pregnant women
by: T. A. Ruzhentsova, et al.
Published: (2021-06-01)

Etiological and immunopathogenetic aspects of multiorgan failure development in coronavirus disease (COVID-19)
by: T. V. Ashcheulova, et al.
Published: (2024-07-01)

Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01)

Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection
by: Julian Heuberger, et al.
Published: (2021-03-01)

Efficacy and safety of interferon alfa-2b in the complex therapy of patients with chronic bacterial prostatitis: a multicenter randomized clinical trial
by: Kh. S. Ibishev, et al.
Published: (2023-04-01)

Viferon Suppositoria in Therapy of Relapsing Herpesvirus Infection in Women
by: A. N. Vasilyev, et al.
Published: (2020-05-01)

STING agonists as promising vaccine adjuvants to boost immunogenicity against SARS-related coronavirus derived infection: possible role of autophagy
by: Aysa Rezabakhsh, et al.
Published: (2024-06-01)

Complex therapy for patients with respiratory infections and respiratory diseases
by: I. V. Kovaleva, et al.
Published: (2021-06-01)

The Value of the Interferon Inductors in the Treatment and Prevention of Respiratory Infections
by: O. V. Kladova, et al.
Published: (2016-11-01)

Outcome of COVID-19 in children: results of a 12-month follow-up
by: T. M. Chernova, et al.
Published: (2022-07-01)

The effectiveness of the use of the drug recombinant interferon alfa-2b for the prevention of acute respiratory infections in preschool children
by: S. A. Drakina, et al.
Published: (2019-12-01)

Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
by: Vahid Rajabali Zadeh, et al.
Published: (2025-05-01)

RNA interference is the basis of human antiviral defense
by: J. N. Muratkhodjaev, et al.
Published: (2022-11-01)

Features of the functioning of the innate and adaptive immunity system in patients with COVID-19 of the older age group
by: O. N. Scheglovitova, et al.
Published: (2023-10-01)

IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
by: Sophia Davidson, et al.
Published: (2016-08-01)

Vaginal biocenosis in pregnant women with recurrent bacterial vaginosis after treatment with recombinant human interferon alpha-2b
by: A. V. Podgornaya, et al.
Published: (2019-09-01)

Universal approaches to the treatment of acute respiratory viral infection and influenza
by: A. V. Mordyk, et al.
Published: (2023-08-01)

Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use
by: A. V. Surov,, et al.
Published: (2014-07-01)

Comprehensive transcriptome assessment in PBMCs of post-COVID patients at a median follow-up of 28 months after a mild COVID infection reveals upregulation of JAK/STAT signaling and a prolonged immune response
by: Serena Fineschi, et al.
Published: (2025-05-01)

The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial
by: Wenqi Huang, et al.
Published: (2025-05-01)

NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B
by: A. S. Polyakov, et al.
Published: (2018-05-01)

ADMINISTRATION CRITERIA FOR INTERFERON-BASED DRUGS AND ITS INDUCERS IN ACUTE RESPIRATORY INFECTIONS IN CHILDREN
by: E. G. Golovacheva, et al.
Published: (2014-07-01)

Interferon status at the women with recurrent genital herpes in combined liposomal RNA treatment
by: A. Sh. Makhmutkhodzhayev, et al.
Published: (2012-06-01)

Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow
by: Dina S. Rusinova, et al.
Published: (2020-06-01)